Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
2 competitors in Attention-Deficit/Hyperactivity Disorder
View Full LandscapeTarget Indication
Attention-Deficit/Hyperactivity Disorder
Clinical Trial
NCT00429091Last updated: 1/2/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
HIV Infection
Human Immunodeficiency Virus Infections
Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Seasonal Allergic Rhinitis
Exocrine Pancreatic Insufficiency, Chronic Pancreatitis